Patent News

All the most recent news stories, updated every Tuesday, to keep you informed of the events in ever-changing and fast paced industry.

MorphoSys settles patent lawsuit with Janssen and Genmab

MorphoSys AG announced that its lawsuit against Janssen Biotech and Genmab A/S has been settled. The parties have agreed to drop the mutual claims related to this litigation. MorphoSys filed a lawsuit in the U.S. District Court of Delaware against Janssen Biotech, and...

read more

Spotify sued for alleged infringement of Yahoo! patents

Spotify is being sued by IP company Excalibur IP for allegedly infringing on patents held by Yahoo!. Excalibur IP filled a lawsuit with the District of Delaware Court on January 28. The complaint accuses Spotify of infringing on four patents which were created at...

read more

Apple secures win against Qualcomm in latest ruling

Apple secured a victory in their ongoing dispute with Qualcomm, after a German court rejected four out of eight infringement claims. The district court found no infringement of the patents. which are related to on-device search. However, the judgment is not final. No...

read more

Court rejects Indivior Suboxone appeal

British pharma company Indivior has suffered a setback as U.S. Federal Court of Appeal rejected their request for another hearing on whether its patents were infringed by a low-cost alternative developed by Dr Reddy. The decision clears the way for India’s Dr Reddy’s...

read more

Japan to consider factory raids in patent litigation

Proposed by the Japan Patent Office, a new law could see courts appoint a neutral expert to search factories for evidence of patent infringement. Patent cases in Japan usually require a high burden of proof on the party claiming infringement. Courts can, however,...

read more

CPA Global announce merger with ipan/Delegate group

IP management and technology businesses CPA Global and ipan/Delegate Group yesterday announced their agreement to merge. The merger will combine the two companies and give customers from both CPA Global and ipan/Delegate Group the group’s combined capabilities, which...

read more

U.S. Supreme Court rejects Helsinn over anti-nausea drug

In a victory for Teva Pharmaceutical Industries, the U.S. Supreme Court today refused to revive Helsinn Healthcare S.A.’s patent on an anti-nausea drug Aloxi. The decision was unanimously upheld in a lower court ruling which canceled Helsinn’s patent on the drug for...

read more